Kezar Life Sciences
83 hedge funds and large institutions have $158M invested in Kezar Life Sciences in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
26% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 31
83% less call options, than puts
Call options by funds: $14K | Put options by funds: $84K
Holders
83
Holding in Top 10
1
Calls
$14K
Puts
$84K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$4.77M | |
| 3 | +$4.47M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.4M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$644K |
Top Sellers
| 1 | -$3.09M | |
| 2 | -$1.19M | |
| 3 | -$869K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$343K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$252K |